Literature DB >> 21839316

Vitiligo: a comprehensive overview Part II: treatment options and approach to treatment.

Lesley M Felsten1, Ali Alikhan1, Vesna Petronic-Rosic2.   

Abstract

Vitiligo is a common skin disorder that results in depigmentation. With the appropriate management, many patients can minimize disease progression, attain repigmentation, and achieve cosmetically pleasing results. There are numerous medical and surgical treatments aimed at repigmentation; therapies for depigmentation are available for patients with recalcitrant or advanced disease. The use of cosmetics at all stages of treatment may be vital to the patient's quality of life. Understanding all the available options helps choose the appropriate treatment plan and tailor it to your patient. Part II of this two-part series on vitiligo discusses the indications for, evidence behind, and adverse effects associated with many of the therapies used for vitiligo. Both conventional medical and surgical options are discussed in addition to several alternative and promising new therapies.
Copyright © 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21839316     DOI: 10.1016/j.jaad.2010.10.043

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  26 in total

1.  Enhanced bleaching treatment: opportunities for immune-assisted melanocyte suicide in vitiligo.

Authors:  Kirsten C Webb; Jonathan M Eby; Vidhya Hariharan; Claudia Hernandez; Rosalie M Luiten; I Caroline Le Poole
Journal:  Exp Dermatol       Date:  2014-07-10       Impact factor: 3.960

2.  Successful treatment of extensive vitiligo with monobenzone.

Authors:  Ole Martin Rordam; Eric William Lenouvel; Martine Maalo
Journal:  J Clin Aesthet Dermatol       Date:  2012-12

3.  Maintenance therapy of adult vitiligo with 0.1% tacrolimus ointment: a randomized, double blind, placebo-controlled study.

Authors:  Marine Cavalié; Khaled Ezzedine; Eric Fontas; Henri Montaudié; Emeline Castela; Philippe Bahadoran; Alain Taïeb; Jean-Philippe Lacour; Thierry Passeron
Journal:  J Invest Dermatol       Date:  2014-12-18       Impact factor: 8.551

Review 4.  Phototherapy for Vitiligo: A Systematic Review and Meta-analysis.

Authors:  Jung Min Bae; Han Mi Jung; Bo Young Hong; Joo Hee Lee; Won Joon Choi; Ji Hae Lee; Gyong Moon Kim
Journal:  JAMA Dermatol       Date:  2017-07-01       Impact factor: 10.282

5.  Fibrin glue fixation for suction blister epidermal grafting in two patients with stable vitiligo.

Authors:  Hyojin Kim; Jeong-Nan Kang; Sung-Hwan Hwang; Jong-Keun Seo; Ho-Suk Sung
Journal:  Ann Dermatol       Date:  2014-11-26       Impact factor: 1.444

6.  CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo.

Authors:  Mehdi Rashighi; Priti Agarwal; Jillian M Richmond; Tajie H Harris; Karen Dresser; Ming-Wan Su; Youwen Zhou; April Deng; Christopher A Hunter; Andrew D Luster; John E Harris
Journal:  Sci Transl Med       Date:  2014-02-12       Impact factor: 17.956

7.  A Retrospective Study of 3,000 Indian Patients with Vitiligo Treated with Phototherapy or Topical Monotherapy.

Authors:  Jagdish Sakhiya; Dhruv Sakhiya; Neha Virmani; Trusha Gajjar; Jitesh Kaklotar; Ravi Khambhati; Feral Daruwala; Nimish Dudhatra
Journal:  J Clin Aesthet Dermatol       Date:  2021-02-01

8.  Epidermal curettage technique (ECT) for tissue harvest from the donor area for melanocyte autologous grafting in cases of vitiligo.

Authors:  Carlos D' Apparecida Santos Machado Filho; Fabio Roismann Timoner
Journal:  An Bras Dermatol       Date:  2014 Jul-Aug       Impact factor: 1.896

9.  A comparative study of combined treatment with fractional carbon dioxide and targeted ultraviolet B phototherapy for facial vitiligo.

Authors:  Silada Kanokrungsee; Kumutnart Chanprapaph; Chayada Chaiyabutr; Vasanop Vachiramon
Journal:  Lasers Med Sci       Date:  2016-06-13       Impact factor: 3.161

10.  Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo.

Authors:  Jillian M Richmond; James P Strassner; Lucio Zapata; Madhuri Garg; Rebecca L Riding; Maggi A Refat; Xueli Fan; Vincent Azzolino; Andrea Tovar-Garza; Naoya Tsurushita; Amit G Pandya; J Yun Tso; John E Harris
Journal:  Sci Transl Med       Date:  2018-07-18       Impact factor: 17.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.